Sotera Health Company (SHC) Stock Forecast
SHC analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 4.20 / 5 from 10 analysts
- Price target
- $22.61 average of analyst targets
- Upside to target
- +26.4% from the latest close
- Next earnings
- November 3, 2026 EPS estimate $0.24
- 52-week range
- $13.13 – $19.57
SHC analyst ratings
10 analystsNumber of analysts at each rating.
SHC price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
SHC earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.27 | $0.26 | $0.27 | $0.26 | +3.3% | 10 |
| Current fiscal year (2026) | $0.98 | $0.98 | $0.99 | $0.86 | +14.4% | 10 |
| Next fiscal year (2027) | $1.07 | $1.03 | $1.13 | $0.98 | +9.3% | 10 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
SHC revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $319.8M | $317.0M | $324.6M | +2.7% | 9 |
| Current fiscal year (2026) | $1.25B | $1.24B | $1.25B | +7.2% | 9 |
| Next fiscal year (2027) | $1.32B | $1.31B | $1.33B | +5.9% | 9 |
SHC EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
SHC revenue: reported and forecast
SHC EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.27 | $0.27 | $0.27 | $0.27 | $0.27 | −0.8% | 1 up · 0 down |
| Current fiscal year (2026) | $0.97 | $0.98 | $0.98 | $0.98 | $0.98 | +1.8% | 1 up · 0 down |
| Next fiscal year (2027) | $1.06 | $1.07 | $1.07 | $1.08 | $1.07 | +1.4% | 1 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
SHC earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; SHC beat in 11 of 12.
What analysts expect from SHC
10 analysts cover Sotera Health; their consensus rating is buy (4.20 on a 1–5 scale, where 5 is a strong buy). The average price target is $22.61, 26.4% above the latest close of $17.89. Analysts expect earnings of $0.98 per share for 2026, +14.4% from a year earlier. For 2027 the average estimate is $1.07 per share on revenue of $1.3 billion. Sotera Health beat the EPS estimate in 11 of the last 12 quarters.
Related: SHC income statement, SHC key metrics, SHC chart. See the SHC stock overview for the latest quote and news.
SHC forecast FAQ
What is Sotera Health's price target?
The average analyst price target for Sotera Health is $22.61, 26.4% above the latest close of $17.89.
Is Sotera Health a buy, hold or sell?
Of 10 analysts covering Sotera Health, 5 rate it a strong buy, 3 a buy, 1 a hold, 1 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Sotera Health's EPS forecast?
Analysts forecast $0.98 per share for 2026 (range $0.98 to $0.99); for 2027 the estimate is $1.07.
What is Sotera Health's revenue forecast?
The average revenue estimate for 2026 is $1.2 billion, growth of 7.2%; for 2027 it is $1.3 billion.
When does Sotera Health report earnings?
Sotera Health is expected to report results for the quarter ending September 30, 2026 on November 3, 2026 before the market opens; the EPS estimate is $0.24.
Does Sotera Health usually beat earnings estimates?
Sotera Health reported EPS at or above the analyst estimate in 11 of the last 12 quarters.